See every side of every news story
Published loading...Updated

Longevity advocate Bryan Johnson ditches rapamycin over side effects

Summary by The Express Tribune
Tech entrepreneur and longevity advocate Bryan Johnson has discontinued his use of rapamycin, a controversial anti-ageing drug, after concerns it may have accelerated ageing rather than reversed it. The 47-year-old millionaire, known for spending $2 million annually on cutting-edge treatments to slow ageing, revealed in a social media post that his team concluded the risks of lifelong rapamycin use outweighed its benefits. Johnson, who undertook…

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Health Rising broke the news in on Saturday, February 1, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.